Resources
About Us
Africa Medical Devices Market Size, Share, Forecast, & Trends Analysis by Product (IVD, Monitoring, Imaging, Drug Delivery, Surgical, Bioimplants, Stimulation), Risk Type, Application (Cardiology, General Surgery, Orthopedics) End User—Forecast to 2031
Report ID: MRHC - 1041419 Pages: 120 Nov-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample ReportThe growth of this market is driven by the increasing prevalence of chronic diseases coupled with the geriatric population, technological advancements in medical devices, growing awareness about advanced medical technologies, and rising initiatives to increase accessibility to treatment. Furthermore, developing healthcare infrastructure in African countries and emerging medical tourism in African countries. are expected to generate opportunities for the stakeholders in this market.
The rising prevalence of chronic diseases and the growing geriatric population in Africa are driving significant growth in the region's medical devices market. The increasing burden of chronic conditions has led to higher patient visits to healthcare facilities, thereby fueling demand for medical equipment. According to an article published by the World Economic Forum (Switzerland) in September 2022, non-communicable diseases are on the rise across the continent, with 50-88% of deaths in several African countries attributed to chronic diseases.
To address these challenges and reduce mortality rates, governments across Africa are launching various initiatives aimed at strengthening healthcare infrastructure. These programs are driving the increased use and adoption of medical devices in treatment regimens. As highlighted by the World Economic Forum, several African countries are implementing new strategies to combat chronic diseases. For example, the PEN-Plus strategy, introduced in 2022 at the 72nd session of the WHO’s Regional Committee for Africa in Lomé, Togo, urges African nations to adopt standardized programs for treating chronic and severe non-communicable diseases. These efforts are expected to further accelerate the adoption of medical devices across healthcare facilities in the region.
The high disease burden and shortage of skilled healthcare professionals in many African countries present significant challenges to the healthcare sector. These factors underscore the need for increased awareness of new solutions and advanced medical technologies to alleviate the strain caused by these health issues. According to the World Health Organization (WHO), the average doctor-to-population ratio in Africa is approximately two doctors per 10,000 people, compared to 35.5 doctors per 10,000 people in the United States. This disparity highlights the critical need for accessible and advanced medical technologies across the region.
Additionally, various initiatives and strategies developed by organizations to improve healthcare access in Africa have contributed to growing awareness about advanced medical technologies. For example, as reported by the African Development Bank (Côte d'Ivoire) in January 2024, the bank entered into an agreement with HealthTech Hub Africa (Rwanda) to support the development of a pan-African blueprint aimed at accelerating health tech innovations across the continent. This growing awareness of medical technologies is expected to drive demand for and increase the adoption of medical devices across African countries.
The rising focus of African governments on strengthening healthcare infrastructure is expected to offer growth opportunities. For instance, the African Development Bank developed a Quality Health Infrastructure in Africa 2021-2030 (SQHIA) strategy to help address Africa’s healthcare infrastructure deficits and offer scope for development.
Recent investments by public-private organizations also boost the adoption of medical devices in Africa. For instance, in June 2023, the World Bank (U.S.) approved a USD 450 million Program-for-Results loan to support the Moroccan government in implementing health reform to improve the provision of quality public health services in the countries.
Over the past three years, Tanzania’s health sector has undergone significant improvements, marking a period of unprecedented progress. One such development includes the expansion and improvement of health infrastructure, where the number of health service delivery facilities has increased from 8,549 in 2021 to 9,693 in 2024 (Source: Ministry of Health, Tanzania).
Based on products, the Africa medical devices market is segmented into monitoring devices, diagnostic devices, drug delivery devices, surgical devices, bio implants & stimulation devices, automation & robotics, imaging devices, and other devices. In 2024, the monitoring devices segment is estimated to account for the largest share of the Africa medical devices market.
Monitoring devices are majorly used for patients’ health monitoring in real time and quickly. It helps in diagnosing & quantifying a patient’s condition. Moreover, recent product launches by key market players are driving the growth of the Africa medical devices market. For instance, in October 2023, Turtle Shell Technologies Private Limited (Dozee) (India) launched Dozee Pro Ex, which is an advanced ambulatory patient monitoring system. Dozee Pro Ex device offers wearable wireless sensors that help in continuous monitoring of vital signs, which include blood pressure, ECG rhythm, heart rate, respiration rate, oxygen saturation, and temperature. Furthermore, the availability of these devices in Africa countries also contributes to the largest share of the segment.
In 2024, South Africa is estimated to account for the largest share of the Africa medical devices market. South Africa holds a significant share of the African medical devices market, primarily driven by the high prevalence of both communicable and non-communicable diseases, as well as the government’s increasing focus on healthcare sector development. According to the IDF Diabetes Atlas 2021, South Africa is the leading country in the region for diabetes prevalence, with 4.2 million people aged 20–79 living with the condition in 2021. This number is projected to increase by 76.3%, reaching 7.5 million by 2045.
As a result, there is a growing demand for medical devices, particularly in-vitro diagnostics and diabetic care products, which are essential for diagnosing and managing both communicable and non-communicable diseases in hospitals, diagnostic labs, and home care settings. This rising adoption of medical devices to address the disease burden in the country is a key factor driving the growth of the medical devices market across Africa.
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past years (2021-2024).
The key players profiled in the Africa medical devices market report are Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Abbott Laboratories (U.S.), Smith & Nephew Plc (U.K.), Coloplast Corp. (Denmark), Zimmer Biomet. (U.S), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company. (U.S), Olympus Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Cardinal Health. (U.S.), and Medtronic plc (Ireland).
Particulars |
Details |
Number of Pages |
120 |
Format |
|
Forecast Period |
2024–2031 |
Base Year |
2023 |
CAGR (Value) |
7.7% |
Market Size (Value) |
USD 7.14 Billion by 2031 |
Segments Covered |
By Product
By Risk Type
By Application
By End User
|
Countries Covered |
South Africa, Egypt, Algeria, Nigeria, Morocco, Kenya, Tunisia, Côte D’Ivoire, Tanzania, Cameroon, and the Rest of Africa. |
Key Companies |
Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Abbott Laboratories (U.S.), Smith & Nephew Plc (U.K.), Coloplast Corp. (Denmark), Zimmer Biomet. (U.S), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company. (U.S), Olympus Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Cardinal Health. (U.S.), and Medtronic plc (Ireland) |
The Africa medical devices market size was valued at $3.99 billion in 2023.
The market is projected to grow from $4.26 billion in 2024 to $7.14 billion by 2031.
The Africa medical devices market analysis indicates a significant growth to reach $7.14 billion by 2031, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.
The key companies operating in this market include Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Abbott Laboratories (U.S.), Smith & Nephew Plcgastri (U.K.), Coloplast Corp. (Denmark), Zimmer Biomet. (U.S), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company. (U.S), Olympus Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Cardinal Health. (U.S.), and Medtronic plc (Ireland).
A prominent market trend in the Africa medical devices market is rising investments by key players, integration of AI and Robotics in medical devices, and increasing demand for wearable devices.
By product, the Invitro Diagnostics (IVD) segment is forecasted to hold the largest market share. By risk type, the moderate-risk medical devices segment is expected to dominate the market. By application, the cardiology segment is expected to dominate the market. By end user, the Hospitals & Clinics segment is poised to record the dominant position in the market. By geography, the South Africa segment is slated to register the largest market share
By region, South Africa is Expected to register the largest share of the Africa medical devices market. The rising prevalence of chronic, infectious, and non-communicable diseases and increased government focus on strengthening the country’s healthcare sector are the factors contributing to regional growth.
The primary drivers of the Africa medical devices market growth include the increasing Prevalence of chronic diseases coupled with geriatric populations, technological advancements in medical devices, growing awareness about advanced medical technologies, and rising initiatives to increase accessibility to treatment.
Published Date: Nov-2024
Published Date: Nov-2024
Published Date: Aug-2024
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates